Indeed, 100% of recovered COVID-19 patients in a recent study had virus-specific CD4+ T cells (Grifoni et al. 2020), which is highly suggestive of a critical role of adaptive immunity in successful clearance of SARS-CoV-2. The gene discussed is CD4; the disease is COVID-19.